Cantor Fitzgerald’s Tevogen Inc. Warrant TVGNW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-260,500
Closed -$18.2K 562
2025
Q2
$18.2K Hold
260,500
﹤0.01% 408
2025
Q1
$14K Hold
260,500
﹤0.01% 277
2024
Q4
$16.4K Hold
260,500
﹤0.01% 244
2024
Q3
$3.36K Hold
260,500
﹤0.01% 204
2024
Q2
$7.68K Hold
260,500
﹤0.01% 226
2024
Q1
$20.8K Sell
260,500
-75,000
-22% -$4.49K ﹤0.01% 208
2023
Q4
$1.51M Buy
335,500
+150,000
+81% +$6.09K 0.31% 48
2023
Q3
$9.28K Hold
185,500
﹤0.01% 514
2023
Q2
$7.66K Hold
185,500
﹤0.01% 532
2023
Q1
$14.8K Hold
185,500
﹤0.01% 612
2022
Q4
$1K Hold
185,500
﹤0.01% 699
2022
Q3
$22K Hold
185,500
﹤0.01% 683
2022
Q2
$30K Hold
185,500
﹤0.01% 735
2022
Q1
$50K Buy
+185,500
New +$69K ﹤0.01% 332

Other funds holding TVGNW

Cantor Fitzgerald's TVGNW Position: Q3 2025 in Review

Cantor Fitzgerald sold out of Tevogen Inc. Warrant (TVGNW) in Q3 2025, closing a stake of 260,500 shares — an estimated $18.2K sold.

Cantor Fitzgerald first reported a position in TVGNW in Q1 2022 and held it in 14 quarters. The position peaked at $1.51M in Q4 2023. 35 funds tracked by Wall St. Rank hold TVGNW as of Q3 2025.

  • Cantor Fitzgerald reported no remaining Tevogen Inc. Warrant position as of Q3 2025 after selling out during the quarter.
  • Cantor Fitzgerald sold 260,500 Tevogen Inc. Warrant shares in Q3 2025, an estimated $18.2K.
  • Cantor Fitzgerald first reported a position in Tevogen Inc. Warrant in Q1 2022 and held it in 14 quarters.
  • Cantor Fitzgerald's Tevogen Inc. Warrant position peaked at $1.51M in Q4 2023.
  • 35 funds tracked by Wall St. Rank held Tevogen Inc. Warrant as of Q3 2025.

Based on Cantor Fitzgerald's 13F filing for Q3 2025, filed 14 Nov 2025.